Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Duloxetine not different from placebo in double-blind depression study

July 7, 1997

Phase III trials show significant positive effect for sertindole on negative symptoms

July 7, 1997

Summary of perospirone clinical trials

July 7, 1997

Selective dopamine autoreceptor agonists prepared by American Home Products

July 7, 1997

SM-13496 preferentially affects mesocortical dopaminergic system

July 4, 1997

Cholinesterase inhibition with metrifonate studied in rats

July 4, 1997

Citicoline improves cognitive impairment in animals and elderly subjects

July 4, 1997

CRF modulator introduced in Italy

July 4, 1997

CCK-B antagonist is not effective in anxiety disorders

July 4, 1997

Etifoxine compared to buspirone for adjustment disorder with anxiety

July 4, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 7, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 6, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...